MAPT and Parkinson disease: Consequently, we sought for investigating how the CSF levels of α-syn, Aβ1–42, t-tau, and p-tau varied and changed over the progression of PD and SWEDD in addition to investigating whether the level of differences in the biomarkers could be used for differentiating these two conditions.